Thrombospondin 1 Suppresses Insulin Signaling in C2C12 Myotubes

Kobe J Med Sci. 2016 Jun 16;62(1):E13-8.

Abstract

Thrombospondin 1 (TSP-1) is abundantly expressed in visceral adipose tissue and this expression is up-regulated in obese humans and rodents. Recent studies showed that genetic deletion of TSP-1 protects mice from diet-induced insulin resistance. However, the molecular mechanism is largely unknown. In this study, we examined the effect of recombinant TSP-1 on insulin signaling in cultured cells from insulin sensitive tissues to investigate whether TSP-1 could act as an adipokine. Here we show that treatment with recombinant TSP-1 suppressed insulin signaling in cultured muscle cells, which was accompanied by the activation of stress signaling such as JNK, p38, and IKK. These results suggest that TSP-1 acts as an adipokine which is involved in the pathogenesis of obesity-induced insulin resistance. Thus, TSP-1 could be a potential target for the treatment of insulin resistance and metabolic disease related to insulin resistance.

Keywords: IKK; Insulin resistance; JNK; Obesity; Thrombospondin 1; p38.

MeSH terms

  • Adipokines / metabolism
  • Animals
  • Cell Line
  • Hep G2 Cells
  • Humans
  • Insulin / metabolism*
  • Insulin Resistance
  • MAP Kinase Signaling System / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Muscle Fibers, Skeletal / drug effects
  • Muscle Fibers, Skeletal / metabolism*
  • Recombinant Proteins / pharmacology
  • Signal Transduction / drug effects
  • Thrombospondin 1 / genetics
  • Thrombospondin 1 / metabolism*
  • Thrombospondin 1 / pharmacology

Substances

  • Adipokines
  • Insulin
  • Recombinant Proteins
  • Thrombospondin 1
  • Thbs1 protein, mouse